Edition:
United Kingdom

Syros Pharmaceuticals Inc (SYRS.OQ)

SYRS.OQ on NASDAQ Stock Exchange Global Select Market

11.16USD
15 Aug 2018
Change (% chg)

$-0.26 (-2.28%)
Prev Close
$11.42
Open
$11.40
Day's High
$11.52
Day's Low
$11.11
Volume
5,121
Avg. Vol
64,860
52-wk High
$23.41
52-wk Low
$6.31

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.38 -0.427
Mar '18 0.37 -0.477
FY 2017 Dec '17 0.00 -0.581
Sep '17 0.00 -0.526
Jun '17 0.00 -0.523
Mar '17 1.10 -0.492
FY 2016 Dec '16 0.32 -0.200
Sep '16 0.00 -0.649
Jun '16 0.00 -0.608
Mar '16 0.00 -0.542
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 7 0.46 1.80 0.00 0.00
Quarter Ending Dec-18 7 0.46 1.80 0.00 0.00
Year Ending Dec-18 7 1.63 4.20 0.70 0.00
Year Ending Dec-19 7 2.08 7.07 0.00 43.69
Earnings (per share)
Quarter Ending Sep-18 7 -0.46 -0.43 -0.49 -0.72
Quarter Ending Dec-18 7 -0.49 -0.44 -0.53 -0.67
Year Ending Dec-18 7 -1.85 -1.77 -1.92 -2.99
Year Ending Dec-19 7 -2.02 -1.67 -2.48 -3.24
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.93 32.76
P/E High - Last 5 Yrs. -- 40.66 45.44
P/E Low - Last 5 Yrs. -- 23.69 24.26
Beta -- 0.90 0.89
Price to Sales (TTM) 296.49 3.94 5.75
Price to Book (MRQ) 4.61 4.88 5.47
Price to Tangible Book (MRQ) 4.62 5.70 7.04
Price to Cash Flow (TTM) -- 22.85 23.29
% Owned Institutions 71.22 1.23 2.21

Dividends

  Company industry sector
Dividend Yield -- 1.57 1.51
Dividend Yield - 5 Year Avg -- 1.58 1.52
Dividend 5 Year Growth Rate -- 4.35 5.22
Payout Ratio(TTM) -- 45.85 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 2.27 8.01
Sales (TTM) vs TTM 1 Yr. Ago -- 4.77 5.64
Sales - 5 Yr. Growth Rate -- 9.94 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 14.10 17.61 20.60
EPS (TTM) vs TTM 1 Yr. Ago 11.27 -- --
EPS - 5 Yr. Growth Rate -- 9.75 10.66
Capital Spending - 5 Yr. Growth Rate -- 15.37 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.15 2.22
Current Ratio (MRQ) 13.28 2.94 3.03
LT Debt to Equity (MRQ) 0.01 10.03 12.51
Total Debt to Equity (MRQ) 0.15 14.07 16.85
Interest Coverage (TTM) -- 35.77 32.63

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.71 54.37
Gross Margin - 5 Yr. Avg. -- 52.10 52.17
EBITD Margin (TTM) -3,454.79 -- --
EBITD - 5 Yr. Avg -- 18.48 10.65
Operating Margin (TTM) -3,553.46 14.31 4.32
Operating Margin - 5 Yr. Avg. -- 14.43 6.06
Pre-Tax Margin (TTM) -3,527.29 14.80 5.18
Pre-Tax Margin - 5 Yr. Avg. -- 14.82 6.49
Net Profit Margin (TTM) -3,527.29 11.05 1.48
Net Profit Margin - 5 Yr. Avg. -- 11.12 2.77
Effective Tax Rate (TTM) -- 23.22 23.11
Effective Tax Rate - 5 Yr. Avg. -- 23.48 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 25,782 952,976,483 860,364,356
Net Income/Employee (TTM) -909,400 112,117,219 101,205,920
Receivable Turnover (TTM) -- 5.72 5.87
Inventory Turnover (TTM) -- 2.63 3.41
Asset Turnover (TTM) 0.02 0.96 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -62.53 11.58 11.13
Return on Assets - 5 Yr. Avg. -- 12.95 12.40
Return on Investment (TTM) -68.14 15.07 14.61
Return on Investment - 5 Yr. Avg. -- 16.90 16.13
Return on Equity (TTM) -442.37 16.59 16.33
Return on Equity - 5 Yr. Avg. -- 17.97 17.39
  1 Year 3 Year 5 Year
Sales % 0.00 -- --
EPS (TTM) % -165.27 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Syros Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -6.81 -10.02 54 23
13 Week -9.09 -13.51 96 33
26 Week 8.91 0.63 99 28
52 Week 12.35 -4.77 99 12
YTD 31.66 15.63 99 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 75.18%
# of Holders: 99
Total Shares Held: 25,302,461
3 Mo. Net Change: 1,898,039
# New Positions: 22
# Closed Positions: 6
# Increased Positions: 66
# Reduced Positions: 18
# Net Buyers: 48
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.